• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素与阿尔茨海默病的睡眠障碍。

Melatonin and Sleep Disturbances in Alzheimer's Disease.

机构信息

Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.

Department of Neurology, Headache Centre, San Lazzaro Hospital, Alba, Italy.

出版信息

CNS Neurol Disord Drug Targets. 2021;20(8):736-754. doi: 10.2174/1871527320666210804155617.

DOI:10.2174/1871527320666210804155617
PMID:34348635
Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by sleep, behavioral, memory, and cognitive deteriorations. Sleep disturbance (SD) is a major disease burden in AD, which has a reciprocal relationship with AD pathophysiology. It aggravates memory, behavioral, and cognitive complications in AD. Different studies have found that melatonin hormone levels reduce even in the pre-clinical stages of AD. Melatonin is the primary sleep-regulating hormone and a potent antioxidant with neuroprotective roles. The decrease in melatonin levels can thus promote SD and AD neuropathology. Exogenous melatonin has the potential to alleviate neuropathology and SD in AD by different mechanisms. Various studies have been conducted to assess the efficacy of exogenous melatonin to treat SD in AD. Though most of the studies suggest that melatonin is useful to ameliorate SD in AD, the remaining studies show opposite results. The timing, dosage, and duration of melatonin administration along with disease condition, genetic, environmental, and some other factors can be responsible for the discrepancies between the studies. More extensive trials with longer durations and higher dosage forms and studies including bright light therapy and melatonin agonists (ramelteon, agomelatine, and tasimelteon) should be performed to determine the efficacy of melatonin to treat SD in AD.

摘要

阿尔茨海默病(AD)是一种进行性神经退行性疾病,其特征是睡眠、行为、记忆和认知能力下降。睡眠障碍(SD)是 AD 的主要疾病负担,与 AD 病理生理学呈双向关系。它会加重 AD 中的记忆、行为和认知并发症。不同的研究发现,即使在 AD 的临床前阶段,褪黑素激素水平也会降低。褪黑素是主要的睡眠调节激素,具有神经保护作用的强大抗氧化剂。褪黑素水平的降低因此会促进 SD 和 AD 神经病理学。外源性褪黑素通过不同的机制有可能减轻 AD 的神经病理学和 SD。已经进行了各种研究来评估外源性褪黑素治疗 AD 中 SD 的功效。尽管大多数研究表明褪黑素有助于改善 AD 中的 SD,但其余研究结果则相反。褪黑素给药的时间、剂量和持续时间以及疾病状况、遗传、环境和其他一些因素可能是导致这些研究结果不一致的原因。应该进行更广泛的试验,持续时间更长、剂量更高,并包括亮光疗法和褪黑素激动剂(雷美尔酮、阿戈美拉汀和他司美琼),以确定褪黑素治疗 AD 中 SD 的功效。

相似文献

1
Melatonin and Sleep Disturbances in Alzheimer's Disease.褪黑素与阿尔茨海默病的睡眠障碍。
CNS Neurol Disord Drug Targets. 2021;20(8):736-754. doi: 10.2174/1871527320666210804155617.
2
Pharmacotherapies for sleep disturbances in Alzheimer's disease.用于治疗阿尔茨海默病睡眠障碍的药物疗法。
Cochrane Database Syst Rev. 2014 Mar 21(3):CD009178. doi: 10.1002/14651858.CD009178.pub2.
3
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
4
The use of melatonin in Alzheimer's disease.褪黑素在阿尔茨海默病中的应用。
Neuro Endocrinol Lett. 2002 Apr;23 Suppl 1:20-3.
5
The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease.褪黑素和他司美琼对阿尔茨海默病的作用。
Curr Drug Saf. 2023;18(3):284-296. doi: 10.2174/1574886317666220517125644.
6
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer's Disease Pathogenesis.解析睡眠障碍与阿尔茨海默病发病机制的相互关系。
CNS Neurol Disord Drug Targets. 2021;20(8):723-735. doi: 10.2174/1871527319666200903161249.
7
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.一项关于褪黑素治疗阿尔茨海默病睡眠障碍的多中心、安慰剂对照试验。
Sleep. 2003 Nov 1;26(7):893-901. doi: 10.1093/sleep/26.7.893.
8
Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.褪黑素与强光疗法对机构照料的阿尔茨海默病患者休息-活动紊乱的作用
J Am Geriatr Soc. 2008 Feb;56(2):239-46. doi: 10.1111/j.1532-5415.2007.01543.x. Epub 2007 Dec 7.
9
Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.用于治疗昼夜节律性睡眠-觉醒障碍的已批准褪黑素激动剂的比较综述
Pharmacotherapy. 2016 Sep;36(9):1028-41. doi: 10.1002/phar.1822. Epub 2016 Sep 1.
10
Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances.低剂量非典型抗精神病药物利培酮改善患有睡眠障碍的阿尔茨海默病患者的5年预后。
Pharmacology. 2015;96(3-4):155-62. doi: 10.1159/000435889. Epub 2015 Aug 8.

引用本文的文献

1
Non-Drug and Non-Invasive Therapeutic Options in Alzheimer's Disease.阿尔茨海默病的非药物和非侵入性治疗选择
Biomedicines. 2025 Jan 1;13(1):84. doi: 10.3390/biomedicines13010084.
2
Beyond Wolfram Syndrome 1: The Gene's Role in Alzheimer's Disease and Sleep Disorders.超越沃拉夫综合征 1:该基因在阿尔茨海默病和睡眠障碍中的作用。
Biomolecules. 2024 Oct 31;14(11):1389. doi: 10.3390/biom14111389.
3
Sleep quality, daytime sleepiness, and risk of falling: results from an exploratory cross-sectional study.睡眠质量、日间嗜睡与跌倒风险:一项探索性横断面研究的结果
Eur Geriatr Med. 2025 Feb;16(1):197-204. doi: 10.1007/s41999-024-01092-w. Epub 2024 Nov 7.
4
TRPA1-Related Diseases and Applications of Nanotherapy.TRPA1 相关疾病与纳米治疗应用
Int J Mol Sci. 2024 Aug 26;25(17):9234. doi: 10.3390/ijms25179234.
5
An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission.关于神经递质与阿尔茨海默病的扩展性叙述性综述:治疗干预对神经传递的作用
Mol Neurobiol. 2025 Feb;62(2):1631-1674. doi: 10.1007/s12035-024-04333-y. Epub 2024 Jul 16.
6
Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives.褪黑素作为白血病细胞凋亡的调节因子:分子机制与治疗前景
Front Pharmacol. 2023 Aug 14;14:1224151. doi: 10.3389/fphar.2023.1224151. eCollection 2023.
7
Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases.褪黑素在神经退行性和自身免疫性中枢神经系统疾病中的神经保护作用。
Encephalitis. 2023 Apr;3(2):44-53. doi: 10.47936/encephalitis.2022.00094. Epub 2023 Feb 8.
8
Bioinformatics-Based Analysis of Circadian Rhythm Regulation Mechanisms in Alzheimer's Disease.基于生物信息学的阿尔茨海默病昼夜节律调节机制分析。
J Alzheimers Dis. 2023;94(3):1209-1224. doi: 10.3233/JAD-230177.
9
Therapeutic potential of melatonin in the intervertebral disc degeneration through inhibiting the ferroptosis of nucleus pulpous cells.褪黑素通过抑制髓核细胞铁死亡在椎间盘退变中的治疗潜力。
J Cell Mol Med. 2023 Aug;27(16):2340-2353. doi: 10.1111/jcmm.17818. Epub 2023 Jun 16.
10
Reply to Pluta, R. Comment on "Minich et al. Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements. 2022, , 3934".对普鲁塔的回复,R. 关于《米尼克等人。褪黑素会成为“下一个维生素D”吗?新兴科学、临床应用、安全性及膳食补充剂综述。2022年,,3934》的评论。
Nutrients. 2023 Mar 21;15(6):1507. doi: 10.3390/nu15061507.